Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
53.93
-0.55 (-1.01%)
Apr 29, 2026, 9:33 AM EDT - Market open
Monopar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 361 | 436 | 134 | 5 | 31 | 40 | |
| Market Cap Growth | 85.26% | 225.25% | 2552.79% | -83.48% | -24.23% | -42.34% | |
| Enterprise Value | 224 | 293 | 128 | -3 | 16 | 18 | |
| Last Close Price | 54.48 | 65.30 | 22.00 | 1.70 | 11.85 | 16.05 | |
| PB Ratio | 2.65 | 3.17 | 2.44 | 0.91 | 3.04 | 2.13 | |
| P/TBV Ratio | 2.65 | 3.17 | 2.44 | 0.91 | 3.04 | 2.13 | |
| Debt / Equity Ratio | 0.00 | 0.00 | - | - | 0.00 | - | |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.09 | -1.30 | -1.30 | -1.07 | |
| Quick Ratio | 51.33 | 51.33 | 11.46 | 4.14 | 4.19 | 12.85 | |
| Current Ratio | 51.35 | 51.35 | 11.48 | 4.17 | 4.21 | 12.98 | |
| Return on Equity (ROE) | -14.22% | -14.22% | -51.42% | -107.19% | -72.45% | -52.57% | |
| Return on Assets (ROA) | -10.39% | -10.39% | -29.87% | -53.66% | -39.03% | -30.51% | |
| Return on Capital Employed (ROCE) | -12.10% | -12.10% | -29.40% | -158.00% | -104.30% | -48.20% | |
| Earnings Yield | -3.76% | -3.14% | -11.62% | -166.13% | -34.34% | -22.52% | |
| Buyback Yield / Dilution | -95.53% | -95.53% | -37.09% | -8.70% | -1.97% | -13.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.